BlackRock, Inc. - Dec 31, 2024 SCHEDULE 13G Report for Entrada Therapeutics, Inc. Common Stock (TRDA)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Entrada Therapeutics, Inc. Common Stock
Symbol: TRDA
Shares outstanding: 37.3M shares
Disclosed Ownership: 1.97M shares
Ownership: 5.3%
Form type: SCHEDULE 13G
Date filed: 2/4/2025, 03:45 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.3%	1.97M	1.93M	0	Spencer Fleming	Managing Director